DSS, Inc. (NYSE American: DSS) is finalizing the long-anticipated spin-off of its biotech subsidiary, Impact Biomedical, Inc. The spin-off will reward DSS investors with shares from Impact, and it ...

DSS, Inc. announced its financial results for Q1 2025, showcasing significant growth and improvements in its operations. The company achieved a 28% year-over-year revenue increase, driven by a 30% ...

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of ...

DSS, Inc. DSS announced that the Company plans to distribute to its stockholders common stock of Sharing Services Global Corporation (“Sharing Services” or “SHRG”) that is beneficially held by DSS, ...

ROCHESTER, N.Y., July 31, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value ...

ROCHESTER, N.Y., June 30, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and ...

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial ...

ROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that ...

ROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, ...